Pegylated liposomal doxorubicin in combination with ecteinescidin 743

摘要

A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin ("PLD"), in combination with an effective therapeutic amount of ET-743